Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccination in the elderly: The challenge of immune changes with aging
Annalisa Ciabattini, Christine Nardini, Francesco Santoro, et al.
Seminars in Immunology (2018) Vol. 40, pp. 83-94
Open Access | Times Cited: 351

Showing 1-25 of 351 citing articles:

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
Evan J. Anderson, Nadine Rouphael, Alicia T. Widge, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 25, pp. 2427-2438
Open Access | Times Cited: 1461
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Alberto Mantovani, Charles A. Dinarello, Martina Molgora, et al.
Immunity (2019) Vol. 50, Iss. 4, pp. 778-795
Open Access | Times Cited: 845
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin, Sourabh Shukla, Young Hun Chung, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 8, pp. 646-655
Open Access | Times Cited: 630
Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis
Caifang Zheng, Weihao Shao, Xiaorui Chen, et al.
International Journal of Infectious Diseases (2021) Vol. 114, pp. 252-260
Open Access | Times Cited: 592
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
Amarendra Pegu, Sarah O’Connell, Stephen D. Schmidt, et al.
Science (2021) Vol. 373, Iss. 6561, pp. 1372-1377
Open Access | Times Cited: 548
Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?
Aurelia Santoro, Elisa Bientinesi, Daniela Monti
Ageing Research Reviews (2021) Vol. 71, pp. 101422-101422
Open Access | Times Cited: 359
Next-generation vaccine platforms for COVID-19
Debby van Riel, Emmie de Wit
Nature Materials (2020) Vol. 19, Iss. 8, pp. 810-812
Open Access | Times Cited: 356
Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5
Morgan Brisse, Hinh Ly
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 306
Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease
Luca Liberale, Fabrizio Montecucco, Jean‐Claude Tardif, et al.
European Heart Journal (2020) Vol. 41, Iss. 31, pp. 2974-2982
Open Access | Times Cited: 251
A human circulating immune cell landscape in aging and COVID-19
Yingfeng Zheng, Xiuxing Liu, Wenqing Le, et al.
Protein & Cell (2020) Vol. 11, Iss. 10, pp. 740-770
Open Access | Times Cited: 232
Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms
David J. Lynn, Saoirse C. Benson, Miriam A. Lynn, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 33-46
Open Access | Times Cited: 211
Aging immunity may exacerbate COVID-19
Arne N. Akbar, Derek W. Gilroy
Science (2020) Vol. 369, Iss. 6501, pp. 256-257
Open Access | Times Cited: 201
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Madhumita Shrotri, Maria Krutikov, Tom Palmer, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 11, pp. 1529-1538
Open Access | Times Cited: 186
Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes
Massimiliano Bonafé, Francesco Prattichizzo, Angelica Giuliani, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 33-37
Open Access | Times Cited: 171
Extended interval BNT162b2 vaccination enhances peak antibody generation
Helen Parry, Rachel Bruton, Christine Stephens, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 143
Targeting memory T cell metabolism to improve immunity
Mauro Corrado, Erika L. Pearce
Journal of Clinical Investigation (2022) Vol. 132, Iss. 1
Open Access | Times Cited: 123
Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia
Helen Parry, Graham McIlroy, Rachel Bruton, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 7
Open Access | Times Cited: 116
Characterization of nanoparticles-based vaccines for COVID-19
Giuditta Guerrini, Davide Magrì, Sabrina Gioria, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 6, pp. 570-576
Open Access | Times Cited: 106
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
Ruvim Izikson, Daniel Brüne, Jean-Sébastien Bolduc, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 4, pp. 392-402
Open Access | Times Cited: 88
Global burden and trends of rotavirus infection-associated deaths from 1990 to 2019: an observational trend study
Yuxia Du, Can Chen, Xiaobao Zhang, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 79
Nutrition, Immunosenescence, and Infectious Disease: An Overview of the Scientific Evidence on Micronutrients and on Modulation of the Gut Microbiota
Philip C. Calder, Edwin F. Ortega, Simin Nikbin Meydani, et al.
Advances in Nutrition (2022) Vol. 13, Iss. 5, pp. S1-S26
Open Access | Times Cited: 77
Insights into vaccines for elderly individuals: from the impacts of immunosenescence to delivery strategies
Yingying Hou, Min Chen, Yuan Bian, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 28
The Impact of Immune System Aging on Infectious Diseases
Eugenia Quirós-Roldán, Alessandra Sottini, Pier Giorgio Natali, et al.
Microorganisms (2024) Vol. 12, Iss. 4, pp. 775-775
Open Access | Times Cited: 27
Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors
Dania Zhivaki, Stephanie N. Kennedy, J. Park, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3888-3903.e18
Closed Access | Times Cited: 22
Severe COVID-19 and aging: are monocytes the key?
Brandt D. Pence
GeroScience (2020) Vol. 42, Iss. 4, pp. 1051-1061
Open Access | Times Cited: 133
Page 1 - Next Page

Scroll to top